Secondary infections in critically ill patients with viral pneumonia due to COVID-19 and influenza: a historical cohort study

[1]  Steve B Jones,et al.  Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial , 2021, Lancet.

[2]  L. Westblade,et al.  Bacterial Coinfections in Coronavirus Disease 2019 , 2021, Trends in Microbiology.

[3]  Christopher M. Horvat,et al.  Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19 - Preliminary report , 2021, medRxiv.

[4]  G. Dougan,et al.  Ventilator-associated pneumonia in critically ill patients with COVID-19 , 2021, Critical Care.

[5]  S. Zakynthinos,et al.  ICU-acquired bloodstream infections in critically ill patients with COVID-19☆ , 2020, Journal of Hospital Infection.

[6]  N. Petrosillo,et al.  Incidence of bacterial and fungal bloodstream infections in COVID-19 patients in intensive care: An alarming “collateral effect” , 2020, Journal of Global Antimicrobial Resistance.

[7]  D. Pestaña,et al.  Nosocomial infections associated to COVID-19 in the intensive care unit: clinical characteristics and outcome , 2020, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology.

[8]  O. Pajot,et al.  Bacterial and viral co-infections in patients with severe SARS-CoV-2 pneumonia admitted to a French ICU , 2020, Annals of Intensive Care.

[9]  A. Koohpaei,et al.  Evaluation of bacterial co-infections of the respiratory tract in COVID-19 patients admitted to ICU , 2020, BMC Infectious Diseases.

[10]  Jeri Albano,et al.  Bacterial infections and patterns of antibiotic use in patients with COVID‐19 , 2020, Journal of medical virology.

[11]  D. MacFadden,et al.  Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis , 2020, Clinical Microbiology and Infection.

[12]  L. Argaud,et al.  Early bacterial co-infection in ARDS related to COVID-19 , 2020, Intensive Care Medicine.

[13]  B. Plaud,et al.  Bacterial Pneumonia in COVID-19 Critically Ill Patients: A Case Series , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  P. Pelosi,et al.  Bloodstream infections in critically ill patients with COVID‐19 , 2020, European journal of clinical investigation.

[15]  C. Mantzoros,et al.  Severe obesity, increasing age and male sex are independently associated with worse in-hospital outcomes, and higher in-hospital mortality, in a cohort of patients with COVID-19 in the Bronx, New York , 2020, Metabolism.

[16]  C. Mantzoros,et al.  Severe obesity is associated with higher in-hospital mortality in a cohort of patients with COVID-19 in the Bronx, New York , 2020, Metabolism.

[17]  Mickaël Ohana,et al.  High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study , 2020, Intensive Care Medicine.

[18]  G. Cooke,et al.  Bacterial and fungal co-infection in individuals with coronavirus: A rapid review to support COVID-19 antimicrobial prescribing , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[19]  W. Lim,et al.  Co-infections in people with COVID-19: a systematic review and meta-analysis , 2020, Journal of Infection.

[20]  M. Nishimura,et al.  Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations , 2020, The Lancet Respiratory Medicine.

[21]  Giacomo Grasselli,et al.  Critical Care Utilization for the COVID-19 Outbreak in Lombardy, Italy: Early Experience and Forecast During an Emergency Response. , 2020, JAMA.

[22]  Yan Zhao,et al.  Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. , 2020, JAMA.

[23]  S. Clarke,et al.  Secondary Bacterial Infections Associated with Influenza Pandemics , 2017, Front. Microbiol..

[24]  E. Klein,et al.  The frequency of influenza and bacterial coinfection: a systematic review and meta‐analysis , 2016, Influenza and other respiratory viruses.

[25]  J. McCullers,et al.  Secondary Bacterial Infections in Influenza Virus Infection Pathogenesis , 2014, Current topics in microbiology and immunology.

[26]  W. Lim,et al.  Dexamethasone in Hospitalized Patients with Covid-19 , 2021 .